AI Insight
Stanford researchers used artificial intelligence to identify a natural molecule called BRP that suppresses appetite and promotes fat loss in animal studies. The molecule reduced food intake by up to 50% in test animals and works through a different brain pathway than existing weight-loss drugs like Ozempic. Early results suggest BRP may cause fewer digestive side effects and less muscle loss compared to current treatments.
Why it matters
If successful in human trials, this AI-discovered molecule could provide a new obesity treatment option with potentially fewer side effects than current medications. The research also demonstrates how artificial intelligence can accelerate the discovery of therapeutic compounds by identifying promising candidates from natural sources.
Understand the Science
Stanford researchers have discovered an AI-identified natural molecule that dramatically suppresses appetite and promotes fat loss in animals, potentially offering an Ozempic-like weight-loss treatment without common digestive side effects or significant muscle loss. Called BRP, the molecule reduced food intake by up to 50% and targets a different brain pathway, raising hopes for a more precise obesity treatment if future human trials prove successful.
Source: AI helps Stanford scientists discover a “natural Ozempic” with a surprising advantage